Vanda Pharmaceuticals Inc.
VNDA
$4.36
$0.051.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 325.55M | 340.91M | 374.64M | 376.26M | 387.68M |
| Total Receivables | 44.99M | 44.60M | 47.10M | 42.75M | 41.86M |
| Inventory | 2.17M | 1.92M | 1.73M | 1.61M | 1.47M |
| Prepaid Expenses | 22.21M | 20.48M | 15.42M | 11.76M | 8.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 394.92M | 407.91M | 438.89M | 432.39M | 439.18M |
|
|
|||||
| Total Current Assets | 394.92M | 407.91M | 438.89M | 432.39M | 439.18M |
| Net Property, Plant & Equipment | 12.47M | 12.48M | 12.68M | 8.19M | 8.68M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 110.59M | 112.34M | 114.10M | 115.85M | 117.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 106.76M | 99.21M | 90.54M | 88.69M | 85.91M |
| Total Assets | 624.75M | 631.94M | 656.20M | 645.12M | 651.37M |
|
|
|||||
| Total Accounts Payable | 2.18M | 5.99M | 3.50M | 5.81M | 2.27M |
| Total Accrued Expenses | 50.26M | 34.90M | 31.32M | 31.04M | 34.91M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.68M | 4.39M | 4.27M | 2.45M | 2.43M |
| Total Finance Division Other Current Liabilities | 64.37M | 58.64M | 60.90M | 49.79M | 54.19M |
| Total Other Current Liabilities | 64.37M | 58.64M | 60.90M | 49.79M | 54.19M |
| Total Current Liabilities | 121.49M | 103.92M | 99.98M | 89.09M | 93.79M |
|
|
|||||
| Total Current Liabilities | 121.49M | 103.92M | 99.98M | 89.09M | 93.79M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.96M | 7.35M | 8.09M | 5.49M | 6.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.97M | 9.25M | 9.59M | 9.32M | 9.06M |
| Total Liabilities | 138.42M | 120.52M | 117.66M | 103.89M | 108.86M |
|
|
|||||
| Common Stock & APIC | 716.93M | 714.82M | 712.76M | 709.90M | 706.90M |
| Retained Earnings | -230.99M | -203.79M | -174.29M | -169.38M | -164.06M |
| Treasury Stock & Other | 396.00K | 383.00K | 74.00K | 702.00K | -330.00K |
| Total Common Equity | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 486.33M | 511.42M | 538.55M | 541.22M | 542.52M |
|
|
|||||